Member Info for Mikey279

been watching a while, finally took the plunge today for a large amount.... being managed very well with the minimal placings IMO - so rare to see, will hold long term

There isn't enough volume and spread is too wide to successfully trade it, atm only bored holders selling at losses (likely), shares will go into stickier hands and will move up in time

The quiet shares are the best ones... in my experience. GL ALL

As per strategic review:

By incorporating a dedicated, encrypted messaging function to Feedback's existing Cadran technology, the Directors believe it can become the only medical communication device on the market capable of sharing clinical grade medical imaging directly from a hospital PACS to mobile devices, ensuring the safe handling of patient data and facilitating a secure means of communication for clinicians across the UK. The Directors believe this new product will also be the only communication tool to be a CE marked medical device.

The repositioning of Cadran marks a shift away from a traditional software sales model towards a SaaS (software as a service) model which is anticipated to generate considerably higher recurring revenues for the Company and lead to a new phase of growth. With over 15 million doctors globally, Cadran is uniquely positioned to set new standards in this emerging, sizeable, medical communications market.

Mr 344,852 ... how to lose £600 in 2 hours....., not one for the nervy as it swings wildly and low freefloat, but patience and potential will prevail eventually.

They probably only need a few trusts on board for a nationwide roll out, imagine this - Bleepa being the sole provider of internal imaging communications within the entire NHS, then think internationally other medical organisations...

It's a game changer IMO all for £7m mcap

Spoke to a few clinicians in the nhs who did confirm that whatsapp is the current app of choice (by default not design) and PACS is the current imaging system- they all agreed that bleepa would be extremely beneficial due to existing use

Obviously do your own research... etc

Not really a rumour tbh, the twitter accounts of FDBK and Bleepa are on overdrive at the moment, and as per recent update:

"Whilst driving the development of this exciting opportunity for Cadran, the Board will continue its review of the TexRAD product portfolio. The Company will issue regular updates to the market on the progress of both the TexRAD review and new product opportunities. In the interim, Feedback continues to serve its existing customers across both product portfolios and is committed to the ongoing growth of both Cadran and TexRAD."

It's a complete shift in the company's approach and prospects, plus there's no herd here and only £7m mcap......love it.

selling drying up it seems ! could be multiples from this level IMO......... first mover etc

its ok they will eventually disappear, good thing the spread is nice and wide !

I think you should join them if you're worried about minute by minute movements

Have some patience, a LONG way to go on this imo....

Hi all, hope all is well and money is being made -markets a bit quiet recently.

Some better news on NANO today.

Still in ASO and took some FDBK yesterday, hopefully will go on a run in the coming month!

Good post, did some further research and watched the podcast - Justin’s just angry and lot of straw clutching, he definitely wants a low entry though.

Apps are expensive to develop, maintenance not so much relatively and would usually form a part of any contract. Rollout and scalability is key though moreso than revenues attached to it - everyone knows that apps are developed for exit strategies.

IF the WhatsApp statistic is correct then the market up for grabs is enormous, competition does exist and I don’t believe being GDPR compliant is an actual USP in Bleepa’s case - every competitor will have to be compliant , so what are the USPs:

-CE marked
-Integration with a system already in place at NHS trusts
-High quality images
-NHS contacts

The NHS operate on a trust basis, despite being one organisation, different trusts can still use different systems

Medtech is a hot sector right now and under new direction and leadership, at £7m Mcap with such a simple model i.e recurring revenues on one side and a new app almost at completion on the other , there is significant upside

took a lump.... looks promising at current MCAP, re:placing just looking at results cash at NOV 18 £1.37m, cash burn per year should be around 800k but circa 110k increase in revenues assuming limited COS, so say 700k - so enough to last well into next year? DYOR etc...

Does look more promising than it ever has after the Iran debacle.... many fingers in lots of pies

£1 party ? ;)

IMO

Yes yes yes, not even the main news too !

everyone on strike again? huge gold move last night

$33 over one night?.... good for my ASO nearly at a 100% there

WSG starting to move too !

Otherwise quiet.... hope you are all making ££ or enjoying the sun if not

incredible week for me... also took some WSG now the traders are out, that port contract could be huge

Quick round up:
UJO - placing
IMM - 'boom' for the gamblers?
EQT - placing
MIRI - nice contract with Tencent, but insane amount of cash burn and fundraise needed so be careful there
PYC - contract
VRS - first US order

well....boom for the 'gamblers' that bought in yesterday?